Authors: MERKEL L HAWKINS ED COLUSSI DJ ROSSI D ROJAS CJ HAMEL LT JARVIS MF FINK C STUDT RW SPADA AP CLARK KL PERRONE MH

Citation: L. Merkel et al., PHARMACOLOGICAL CHARACTERIZATION OF AMP579, A NOVEL A(1) A(2) ADENOSINE RECEPTOR AGONIST AND CARDIOPROTECTIVE/, The FASEB journal, 12(4), 1998, pp. 453-453

Authors: COX BF CLARK KL PERRONE MH WELZEL GE GREENLAND BD COLUSSI DJ MERKEL LA

Citation: Bf. Cox et al., CARDIOVASCULAR AND METABOLIC EFFECTS OF ADENOSINE A(1)-RECEPTOR AGONISTS IN STREPTOZOTOCIN-TREATED RATS, Journal of cardiovascular pharmacology, 29(3), 1997, pp. 417-426

Authors: MERKEL L COLUSSI DJ LEWIS DF ROJAS CJ PERRONE MH

Citation: L. Merkel et al., IN-VITRO LIPOLYSIS IN NORMAL AND DIABETIC RATS - EFFECT OF ADENOSINE AGONISTS, The FASEB journal, 9(4), 1995, pp. 750-750

Authors: MERKEL LA HAWKINS ED COLUSSI DJ GREENLAND BD SMITS GJ PERRONE MH COX BF

Citation: La. Merkel et al., CARDIOVASCULAR AND ANTILIPOLYTIC EFFECTS OF THE ADENOSINE AGONIST GR79236, Pharmacology, 51(4), 1995, pp. 224-236

Authors: MERKEL LA RIVERA LM COLUSSI DJ PERRONE MH SMITS GJ COX BF

Citation: La. Merkel et al., INVITRO AND INVIVO CHARACTERIZATION OF AN A1-SELECTIVE ADENOSINE AGONIST, RG14202, The Journal of pharmacology and experimental therapeutics, 265(2), 1993, pp. 699-706

Authors: MERKEL LA RIVERA LM COLUSSI DJ PERRONE MH

Citation: La. Merkel et al., INHIBITION OF EGF-INDUCED VASOCONSTRICTION IN ISOLATED RABBIT AORTIC RINGS WITH THE TYROSINE KINASE INHIBITOR-RG50864, Biochemical and biophysical research communications, 192(3), 1993, pp. 1319-1326